QQ客服 官方微博 反馈留言

	Targeting c‐met receptor tyrosine kinase by the DNA aptamer SL1 as a potential novel therapeutic option for myeloma
	Yibin Zhang; Hongmei Gao; Weihua Zhou; Sunming Sun; Yayue Zeng; Hui Zhang; Long Liang; Xiaojuan Xiao; Jianhui Song; Mao Ye
刊名	J Cell Mol Med
	2018
卷号	Vol.22 No.12页码:5978-5990
关键词	aptamer bortezomib CLN0003_SL1 c‐met receptor multiple myeloma
ISSN号	1582-1838
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5467442
专题	湖南大学
作者单位	1.Key Laboratory of Nanobiological Technology of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, China, 2.Molecular Biology Research Center & Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, China, 3.Molecular Science and Biomedicine Laboratory, State Key Laboratory for Chemo/Biosensing and Chemometrics, College of Biology, College of Chemistry and Chemical Engineering, Hunan University, Changsha, China, 4.Nursing Department, Xiangya Hospital, Central South University, Changsha, China, 5.Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China,
推荐引用方式 GB/T 7714	Yibin Zhang,Hongmei Gao,Weihua Zhou,et al. Targeting c‐met receptor tyrosine kinase by the DNA aptamer SL1 as a potential novel therapeutic option for myeloma[J]. J Cell Mol Med,2018,Vol.22 No.12:5978-5990.
APA	Yibin Zhang.,Hongmei Gao.,Weihua Zhou.,Sunming Sun.,Yayue Zeng.,...&Jing Liu.(2018).Targeting c‐met receptor tyrosine kinase by the DNA aptamer SL1 as a potential novel therapeutic option for myeloma.J Cell Mol Med,Vol.22 No.12,5978-5990.
MLA	Yibin Zhang,et al."Targeting c‐met receptor tyrosine kinase by the DNA aptamer SL1 as a potential novel therapeutic option for myeloma".J Cell Mol Med Vol.22 No.12(2018):5978-5990.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。